Clin Mol Hepatol.
2023 Apr;29(2):384-389. 10.3350/cmh.2023.0066.
Implications of comorbidities in nonalcoholic fatty liver disease
- Affiliations
-
- 1Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
- 2State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
- KMID: 2541424
- DOI: http://doi.org/10.3350/cmh.2023.0066
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Nonalcoholic fatty liver disease and non-liver comorbidities
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
